Home
PRODUCT PIPELINE
Amarin's development pipeline includes a program in Huntington's disease and Myasthenia Gravis, two programs in Parkinson's disease, one in epilepsy, one in memory and a series of programs in cardiovascular disease.LATEST NEWS
- 14-May-2008
Amarin announces private placement for up to $60 million
Full Story - More News »

